|
The early detection of ovarian cancer greatly increases the chances that the disease can be successfully treated. If patients are diagnosed with ovarian cancer before the cancer has spread outside the ovary, nine out of ten women typically survive five years or longer. However, the American Cancer Society estimates that only 25% of ovarian cancer cases are diagnosed in early stages. This is because the symptoms of ovarian cancer are often subtle and not recognized until the disease has progressed to advanced stages. If a patient experiences symptoms of ovarian cancer or an abnormality is detected during a pelvic exam, a number of imaging tests may be ordered to evaluate the situation. If imaging tests warrant further evaluation, a pelvic biopsy may be performed to confirm whether or not the patient has ovarian cancer. Tests Used to Investigate Ovarian AbnormalitiesUltrasound/sonogram: Ultrasound uses sound waves to create clear pictures of the ovaries on a video monitor. Either an abdominal or transvaginal ultrasound exam may be performed to examine the ovaries. An abdominal ultrasound involves moving a hand-held transducer over the abdomen to create images of the ovaries. A transvaginal ultrasound involves inserting an ultrasound probe, slightly larger than a tampon, into the vagina to obtain images of the ovaries. Researchers are investigating whether transvaginal ultrasound may be effective at screening women who are at high risk of ovarian cancer but who do not have any symptoms of the disease.
CT scan: Also called CAT scan (computed tomography), this exam combines the use of a digital computer together with a rotating x-ray device to create detailed cross sectional images of an organ or body part. MRI scan: Also called MR scan (magnetic resonance), this exam uses magnetic energy and radio waves to create cross-sectional images of an organ or body part.
|
||||||||||||||
Imaginis.com suscribes to the HONcode principles of the Health on the Net Foundation.
Copyright 1997-2009 Imaginis Corporation. All rights reserved. Imaginis® is a registered service mark of Imaginis Corporation, a health services company. All other trademarks and copyrights are property of their respective owners. Note: Use of this online service is subject to the disclaimer and the terms and conditions contained herein. Information found within the Imaginis.com website or in other sites linked to from Imaginis.com is provided for educational purposes only and is not intended to be used as a substitute for diagnosis and treatment by a medical doctor. Imaginis does not endorse and has no responsibility for the content of any other sites listed on Imaginis.com, and provides links and references merely as a convenience to its users. Seek immediate medical attention if your condition is urgent. Imaginis - The Breast Cancer Resource